Prolight Diagnostics AB

Equities

PRLD

SE0003618230

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-06-27 EDT			5-day change	1st Jan Change
0.154 ^SEK	+3.36%		+19.38%	-48.84%

06-25	Prolight Diagnostics and TTP Provides Update on MicroFlex Development	CI
05-17	Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	MT

Prolight Diagnostics and TTP Provides Update on MicroFlex Development

June 25, 2024 at 04:52 am

Prolight Diagnostics and TTP have developed the Point-of-Care system MicroFlex which brings the benefits of central-lab quality ELISA testing to more distributed environments with a compact and more user-friendly package.

Latest news about Prolight Diagnostics AB

Prolight Diagnostics and TTP Provides Update on MicroFlex Development	06-25	CI
Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	05-17	MT
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-20	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-20	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-26	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Prolight Diagnostics AB Reports Earnings Results for the Ten Months Ended December 31, 2022	23-04-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Seven Months Ended September 30, 2022	22-11-29	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-28	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-21	CI
Prolight Diagnostics AB signed an agreement to acquire Psyros Diagnostics Ltd for SEK 65 million.	22-01-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-04	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-09	CI

Chart Prolight Diagnostics AB

Duration

Period

More charts

Company Profile

Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.

Sector

Biotechnology & Medical Research

Calendar

2024-08-27 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
PROLIGHT DIAGNOSTICS AB	-48.84%	7.26M
EXACT SCIENCES CORPORATION	-42.96%	7.8B
GUARDANT HEALTH, INC.	+3.48%	3.53B
IOVANCE BIOTHERAPEUTICS, INC.	-0.68%	2.24B
BGI GENOMICS CO., LTD.	-26.79%	1.84B
VERACYTE, INC.	-22.17%	1.66B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+6.87%	951M
CAREDX, INC	+27.50%	811M
SEEGENE, INC.	-7.86%	670M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-27.45%	533M

Bio Diagnostics & Testing